Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-024501)

Filing Details

Accession Number:: 0001181431-10-024501
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-05-05 13:00:00
Reporting Period:: 2010-05-03

Filing Date:: 2010-05-05
Accepted Time:: 2010-05-05 14:55:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1040416	Inspire Pharmaceuticals Inc	ISPH	Pharmaceutical Preparations (2834)	043209022

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1145910	R Benjamin Yerxa	C/O Inspire Pharmaceuticals, Inc. 4222 Emperor Blvd., Suite 200 Durham NC 27703	Evp & Chf, Research & Develop	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-05-03	100	$6.82	54,157	No	4	S	Direct
Common Stock	Disposition	2010-05-03	100	$6.80	54,057	No	4	S	Direct
Common Stock	Disposition	2010-05-03	39	$6.79	54,018	No	4	S	Direct
Common Stock	Disposition	2010-05-03	161	$6.78	53,857	No	4	S	Direct
Common Stock	Disposition	2010-05-03	300	$6.77	53,557	No	4	S	Direct
Common Stock	Disposition	2010-05-03	100	$6.76	53,457	No	4	S	Direct
Common Stock	Disposition	2010-05-03	200	$6.75	53,257	No	4	S	Direct
Common Stock	Disposition	2010-05-03	571	$6.70	52,686	No	4	S	Direct
Common Stock	Disposition	2010-05-03	429	$6.69	52,257	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Sales Plan Agreement adopted by the Reporting Person on June 3, 2009.